July 11, 2012
A Washington federal judge ruled Monday that AstraZeneca LP was not responsible for warning a Seroquel user that the antipsychotic could cause a neurological disorder, though he declined to address whether overpromotion of a drug imposes a duty to warn on its manufacturer.